Monopar Therapeutics, Inc. (MNPR)
74.60
-2.44
(-3.17%)
USD |
NASDAQ |
Dec 12, 16:00
74.46
-0.14
(-0.19%)
After-Hours: 20:00
Monopar Therapeutics Shareholders Equity (Quarterly): 141.56M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 702.29M |
| Travere Therapeutics, Inc. | 73.56M |
| Xenetic Biosciences, Inc. | 3.956M |
| KalVista Pharmaceuticals, Inc. | 17.00M |
| BeyondSpring, Inc. | -31.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 144.20M |
| Total Liabilities (Quarterly) | 2.639M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 56.10 |
| Net Debt Paydown Yield | -0.00% |